Cardiovascular Disease in Women
Submission Deadline: 30 Mar 2022
Guest Editor
Special Issue Information
Dear Colleagues,
Cardiovascular diseases remain the leading cause of morbidity and mortality in women despite advances in prevention, diagnosis, and treatment. Although cardiovascular diseases have been well studied in men, it is now recognized that there are important sex-based differences and not all findings are applicable to women. This has led to a resurgence of interest in identifying contributors to cardiovascular diseases in women as well as guide pharmacotherapeutic and percutaneous or surgical interventions to improve clinical outcomes. This special issue highlights the state-of-the-art in our understanding of cardiovascular diseases in women with a focus on epidemiology and social determinants of cardiovascular health and disease; pregnancy and cardiovascular disease as well as the effect of pregnancy-related complications on future disease; the role of comorbidities on symptoms, presentation, and treatment selection; and sex-based differences in treatment and clinical outcomes of cardiovascular diseases in women. These issues impact chest pain syndromes and coronary artery diseases, valvular heart disease, peripheral artery and cerebrovascular diseases, and pulmonary vascular diseases.
Dr. Jane A. Leopold
Guest Editor
Keywords
- Cardiovascular disease in women
- Acute coronary syndromes
- Myocardial infarction
- Percutaneous coronary intervention
- Coronary artery bypass grafting surgery
- Peripheral arterial disease
- Cerebrovascular disease
- Stroke
- Pulmonary vascular disease
- Pregnancy
- Social determinants of health
- Epidemiology
- Drugs
Published Papers (9)
Cardiovascular Events Among Women with Premature Ovarian Insufficiency: A Systematic Review and Meta-Analysis
Rev. Cardiovasc. Med. 2023, 24(7), 193; https://doi.org/10.31083/j.rcm2407193
(This article belongs to the Special Issue Cardiovascular Disease in Women)
Reappraising Ischemic Heart Disease in Women
Rev. Cardiovasc. Med. 2023, 24(4), 118; https://doi.org/10.31083/j.rcm2404118
(This article belongs to the Special Issue Cardiovascular Disease in Women)
Traditional and Emerging Sex-Specific Risk Factors for Cardiovascular Disease in Women
Rev. Cardiovasc. Med. 2022, 23(8), 288; https://doi.org/10.31083/j.rcm2308288
(This article belongs to the Special Issue Cardiovascular Disease in Women)
Sex Differences in the Relationship between New York Heart Association Functional Classification and Survival in Cardiovascular Disease Patients: A Mediation Analysis of Exercise Capacity with Regular Care Data
Rev. Cardiovasc. Med. 2022, 23(8), 278; https://doi.org/10.31083/j.rcm2308278
(This article belongs to the Special Issue Cardiovascular Disease in Women)
Anti-Müllerian Hormone and Cardiometabolic Disease in Women: A Two-Sample Mendelian Randomization Study
Rev. Cardiovasc. Med. 2022, 23(8), 269; https://doi.org/10.31083/j.rcm2308269
(This article belongs to the Special Issue Cardiovascular Disease in Women)
Serum Uric Acid and Hyperuricemia Associate with Coronary Artery Disease among Postmenopausal Women
Rev. Cardiovasc. Med. 2022, 23(7), 222; https://doi.org/10.31083/j.rcm2307222
(This article belongs to the Special Issue Cardiovascular Disease in Women)
Review of Lipid-Lowering Therapy in Women from Reproductive to Postmenopausal Years
Rev. Cardiovasc. Med. 2022, 23(5), 183; https://doi.org/10.31083/j.rcm2305183
(This article belongs to the Special Issue Cardiovascular Disease in Women)
Maternal and Neonatal Outcomes in Pregnancy Complicated with Pulmonary Hypertension
Rev. Cardiovasc. Med. 2022, 23(5), 172; https://doi.org/10.31083/j.rcm2305172
(This article belongs to the Special Issue Cardiovascular Disease in Women)
Aortic Root Dilatation in Hypertensive Patients with Left Ventricular Hypertrophy–Application of A New Multivariate Predictive Model. The Life Study
Rev. Cardiovasc. Med. 2022, 23(3), 95; https://doi.org/10.31083/j.rcm2303095
(This article belongs to the Special Issue Cardiovascular Disease in Women)
